Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vidaza Key To Celgene’s $2.9 Billion Pharmion Purchase

Nov 19 2007

• By Shirley Haley

Related Content

Pharmion Vidaza Phase III Shows First Survival Advantage In Patients With High-Risk Myelodysplastic Syndromes

Aug 02 2007

MGI/SuperGen’s Dacogen On Deck For Late May Launch

May 03 2006

Pharmion Boosts Oncology Pipeline With Cabrellis Acquisition

Nov 17 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window